One of ARK Invest exchange-traded funds run by ETF star Cathie Wood bought over 330,000 shares of CM Life Sciences Inc. (NASDAQ: CMLF) shares altogether on Wednesday, as the price of this ETF was up around 1.7% in Wednesday’s session. This fund is up a fair amount in the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 332,385 shares of CM Life Sciences. At Wednesday’s closing price, this would have valued this purchase at roughly $4.3 million. This is only a small fraction of the total holdings. ARKG is up 76% in the past 52 weeks.
Check out all of ARK Invest’s buys for Wednesday:
|ARKF||4689JP||Z HOLDINGS CORP||566,500|
|ARKG||RPTX||REPARE THERAPEUTICS INC||22,480|
|ARKG||MASS||908 DEVICES INC||31,772|
|ARKG||DRNA||DICERNA PHARMACEUTICALS INC||700|
|ARKG||CMLF||CM LIFE SCIENCES INC||332,385|
|ARKG||CMIIU||CM LIFE SCIENCES II INC||37,200|
|ARKQ||SPFR||JAWS SPITFIRE ACQUISITION CORP||29,301|
|ARKQ||IRDM||IRIDIUM COMMUNICATIONS INC||68,102|
|ARKQ||ACIC||ATLAS CREST INVESTMENT CORP||76,072|
|ARKX||U||UNITY SOFTWARE INC||2,936|
|ARKX||BLDE||BLADE AIR MOBILITY INC||7,817|
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.